Delirium primary prevention: Difference between revisions

Jump to navigation Jump to search
Line 62: Line 62:
Complete information is available at http://www.umcn.nl/Research/Departments/intensive%20care/Pages/vandenBoogaard.aspx
Complete information is available at http://www.umcn.nl/Research/Departments/intensive%20care/Pages/vandenBoogaard.aspx
<ref>{{Cite web  | last =  | first =  | title = Development and validation of PRE-DELIRIC (PREdiction of... [BMJ. 2012] - PubMed - NCBI | url = http://www.ncbi.nlm.nih.gov/pubmed/22323509 | publisher =  | date =  | accessdate = }}</ref>
<ref>{{Cite web  | last =  | first =  | title = Development and validation of PRE-DELIRIC (PREdiction of... [BMJ. 2012] - PubMed - NCBI | url = http://www.ncbi.nlm.nih.gov/pubmed/22323509 | publisher =  | date =  | accessdate = }}</ref>
===Non-Modifiable Risk Factors===
*Cognitive impairment
*Older age (>65 years)
*History of delirium, [[stroke]], neurological disease, falls or gait disorder
*Associating multiple medical aliments
*Gender: Male over females
*Renal or hepatic pathology<ref>{{Cite web  | last =  | first =  | title = Delirium in elderly adults: diagnosis, prevention and treatment | url = http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065676/ | publisher =  | date =  | accessdate = }}</ref>
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Revision as of 05:11, 15 April 2021

Delirium Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Delirium from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case #1

Delirium On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Delirium

All Images
X-rays
Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Delirium

CDC on Delirium

Delirium in the news

Blogs on Delirium

Directions to Hospitals Treating Delirium

Risk calculators and risk factors for Delirium

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

Overview

It is important to prevent delirium as delirium is itself neurotoxic. It is associated with global brain atrophy and white matter disruption. Various non pharmacological and pharmacological interventions are found to be effective to prevent delirium.

Primary Prevention

Non Pharmacological Interventions

Targeted symptomatic intervention can help prevent the emergence of delirium, however, non pharmacological approaches can curtail the incidence of delirium and not effective in preventing recurrence of delirium once delirium has set it. This is why primary prevention is more important. Following are a few preventive strategies for delirium;

Curtail cognitive decline

  • Write names of care providers, the day’s schedule on board
  • Constantly reorient patients to surroundings
  • Activities to stimulate cognitive actions like discussion of current events, structured reminiscence, or word games

Curtail sleep impairment

  • Reduce environmental noise
  • Relaxing activities such as music, back massage

Curtail immobility

  • Minimal use of catheter or other aids which promotes immobility
  • Early mobilization
  • Incorporation of an exercise regiment

Manage difficulties in sight

  • Use of visual aids
  • Use of large fluorescent tapes or objects with illuminations to help in vision

Manage difficulties in hearing

  • Use of aids
  • Ear care

Avoid dehydration

  • Regular hydration
  • Early recognition and prompt treatment.[1]

Pharmacological Interventions

Various pharmacological interventions have shown promising results in prevention of delirium, which are as follows,

  • Post operative delirium
  • Mechanically ventilated medical and surgical ICU patients
  • Acutely ill general medical patients population

Haloperidol

Delirium possibly causes exhaustion leading to respiratory difficulties and a higher incidence of re-intubations. Low dose haloperidol, if given prophylactically in lower doses, have a better prognosis than treatment of delirium. The following benefits were observed,

  • Lower mortality
  • Lower delirium incidence
  • More delirium free days
  • Patients are less likely to remove their tubes or catheters
  • Patients with a higher risk of developing delirium benefited more
  • ICU readmission rate was lower.

Drawbacks of prophylactic treatment with Haloperidol:

  • Unnecessary treatment to patients who were not destined to develop delirium,
  • Side effects of treatment, however during clinical studies there was only a marginal prolongation of QTc and no one developed ventricular arrhythmias.

Targeted delirium prophylaxis is key to the future management of delirium and more studies are needed on this topic. [3]

Prediction of Delirium in ICU

Early prediction of development of delirium in intensive care is very crucial to start non pharmacological treatment and starting prophylactic haloperidol treatment. PRE-DELIRIC model is used to predict delirium in ICU. Automatic version of the PRE-DELIRIC model (Excel and web based) can be downloaded at http://www.umcn.nl/Research/Departments/intensive%20care/Documents/Pre-deliric%20model.htm?language=english, Complete information is available at http://www.umcn.nl/Research/Departments/intensive%20care/Pages/vandenBoogaard.aspx [4]

References

  1. "MMS: Error".
  2. "Practice guideline for the treatment of pati... [Am J Psychiatry. 1999] - PubMed - NCBI".
  3. "Haloperidol prophylaxis in critically ill patients... [Crit Care. 2013] - PubMed - NCBI".
  4. "Development and validation of PRE-DELIRIC (PREdiction of... [BMJ. 2012] - PubMed - NCBI".

Template:WH Template:WS